Free Trial
NASDAQ:IMNN

Imunon (IMNN) Stock Price, News & Analysis

Imunon logo
$7.00 -0.55 (-7.24%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$7.14 +0.15 (+2.07%)
As of 07/25/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Imunon Stock (NASDAQ:IMNN)

Key Stats

Today's Range
$6.51
$7.66
50-Day Range
$5.99
$40.04
52-Week Range
$5.55
$54.75
Volume
283,740 shs
Average Volume
4.07 million shs
Market Capitalization
$149.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$232.50
Consensus Rating
Moderate Buy

Company Overview

Imunon Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
39th Percentile Overall Score

IMNN MarketRank™: 

Imunon scored higher than 39% of companies evaluated by MarketBeat, and ranked 706th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Imunon has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Imunon has only been the subject of 2 research reports in the past 90 days.

  • Read more about Imunon's stock forecast and price target.
  • Earnings Growth

    Earnings for Imunon are expected to grow in the coming year, from ($1.68) to ($1.07) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Imunon is -5.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Imunon is -5.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Imunon has a P/B Ratio of 24.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Imunon's valuation and earnings.
  • Percentage of Shares Shorted

    6.13% of the float of Imunon has been sold short.
  • Short Interest Ratio / Days to Cover

    Imunon has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Imunon has recently decreased by 72.47%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Imunon does not currently pay a dividend.

  • Dividend Growth

    Imunon does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.13% of the float of Imunon has been sold short.
  • Short Interest Ratio / Days to Cover

    Imunon has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Imunon has recently decreased by 72.47%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Imunon has a news sentiment score of -0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.06 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Imunon this week, compared to 2 articles on an average week.
  • Search Interest

    Only 22 people have searched for IMNN on MarketBeat in the last 30 days. This is a decrease of -21% compared to the previous 30 days.
  • MarketBeat Follows

    Only 5 people have added Imunon to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Imunon insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.96% of the stock of Imunon is held by insiders.

  • Percentage Held by Institutions

    Only 4.47% of the stock of Imunon is held by institutions.

  • Read more about Imunon's insider trading history.
Receive IMNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imunon and its competitors with MarketBeat's FREE daily newsletter.

IMNN Stock News Headlines

IMUNON Announces Reverse Stock Split
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Imunon (NASDAQ:IMNN) Cut to Sell at Wall Street Zen
Imunon, Inc. (IMNN) - Yahoo Finance
See More Headlines

IMNN Stock Analysis - Frequently Asked Questions

Imunon's stock was trading at $14.25 at the beginning of 2025. Since then, IMNN shares have decreased by 50.9% and is now trading at $7.00.

Imunon, Inc. (NASDAQ:IMNN) posted its quarterly earnings results on Monday, May, 12th. The company reported ($4.20) earnings per share (EPS) for the quarter, beating the consensus estimate of ($5.25) by $1.05.
Read the conference call transcript
.

Imunon shares reverse split on Friday, July 25th 2025.The 1-15 reverse split was announced on Wednesday, July 23rd 2025. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 24th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of IMNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Imunon investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Energy Transfer (ET), NVIDIA (NVDA), AT&T (T), AbbVie (ABBV) and Broadcom (AVGO).

Company Calendar

Last Earnings
5/12/2025
Today
7/26/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IMNN
CIK
749647
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$255.00
Low Price Target
$210.00
Potential Upside/Downside
+3,221.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.36)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.62 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-427.98%
Return on Assets
-175.03%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.88
Quick Ratio
0.88

Sales & Book Value

Annual Sales
$500 thousand
Price / Sales
298.20
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
24.14

Miscellaneous

Outstanding Shares
21,300,000
Free Float
16,496,000
Market Cap
$149.10 million
Optionable
Not Optionable
Beta
1.93
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:IMNN) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners